Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new algorithm for treating schizophrenia

R Pearsall1, I D Glick, D Pickar

  • 1School of Medicine, University of Tennessee, Knoxville, TN, USA.

Psychopharmacology Bulletin
|November 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Routine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia.

Schizophrenia research·2016
Same author

Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies.

Acta neuropsychiatrica·2016
Same author

Predominant polarity in bipolar disorders: refining or redefining diagnosis?

Acta psychiatrica Scandinavica·2015
Same author

Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy.

International journal of psychiatry in clinical practice·2014
Same author

More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment.

Journal of affective disorders·2014
Same author

Increased parental history of bipolar disorder in the United States: association with early age of onset.

Acta psychiatrica Scandinavica·2013
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

This study offers new algorithms for schizophrenia management, including pharmacologic treatment and managing side effects. Newer atypical antipsychotics are now recommended as the first-choice treatment for schizophrenia.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Medicine

Background:

  • Schizophrenia management requires updated treatment guidelines.
  • Comorbid conditions and side effects complicate treatment.
  • Advances in pharmacotherapy necessitate revised clinical strategies.

Purpose of the Study:

  • To present two algorithms for schizophrenia management.
  • To provide guidance on pharmacologic treatment initiation and maintenance.
  • To offer strategies for managing comorbid psychiatric conditions and adverse drug reactions.

Main Methods:

  • Development of clinical management algorithms.
  • Review of current pharmacologic options for schizophrenia.
  • Integration of evidence-based practices for comorbid conditions and side effects.

Related Experiment Videos

Main Results:

  • Algorithm 1: Strategy for initiating and managing pharmacologic treatment for schizophrenia.
  • Algorithm 2: Guidance for managing common comorbid psychiatric conditions and side effects.
  • Key recommendation: Atypical antipsychotic agents are suggested as the initial treatment of choice.

Conclusions:

  • The presented algorithms offer a comprehensive approach to schizophrenia care.
  • Updated guidelines emphasize the role of atypical antipsychotics in initial therapy.
  • Effective management of schizophrenia involves addressing both the primary illness and associated conditions.